Literature DB >> 29722054

Pathoarchitectonics of the cerebral cortex in chorea-acanthocytosis and Huntington's disease.

J Liu1,2, H Heinsen3,4, L T Grinberg5, E Alho6, E Amaro7, C A Pasqualucci4, U Rüb8, K Seidel8,9, W den Dunnen10, T Arzberger11,12, C Schmitz13, M C Kiessling13, B Bader2,14, A Danek2.   

Abstract

AIMS: Quantitative estimation of cortical neurone loss in cases with chorea-acanthocytosis (ChAc) and its impact on laminar composition.
METHODS: We used unbiased stereological tools to estimate the degree of cortical pathology in serial gallocyanin-stained brain sections through the complete hemispheres of three subjects with genetically verified ChAc and a range of disease durations. We compared these results with our previous data of five Huntington's disease (HD) and five control cases. Pathoarchitectonic changes were exemplarily documented in TE1 of a 61-year-old female HD-, a 60-year-old female control case, and ChAc3.
RESULTS: Macroscopically, the cortical volume of our ChAc cases (ChAc1-3) remained close to normal. However, the average number of neurones was reduced by 46% in ChAc and by 33% in HD (P = 0.03 for ChAc & HD vs. controls; P = 0.64 for ChAc vs. HD). Terminal HD cases featured selective laminar neurone loss with pallor of layers III, V and VIa, a high density of small, pale, closely packed radial fibres in deep cortical layers VI and V, shrinkage, and chromophilia of subcortical white matter. In ChAc, pronounced diffuse astrogliosis blurred the laminar borders, thus masking the complete and partial loss of pyramidal cells in layer IIIc and of neurones in layers III, V and VI.
CONCLUSION: ChAc is a neurodegenerative disease with distinct cortical neurodegeneration. The hypertrophy of the peripheral neuropil space of minicolumns with coarse vertical striation was characteristic of ChAc. The role of astroglia in the pathogenesis of this disorder remains to be elucidated.
© 2018 British Neuropathological Society.

Entities:  

Keywords:  minicolumn; neurodegenerative disease; neurone number; selective vulnerability; stereology

Year:  2018        PMID: 29722054      PMCID: PMC6994229          DOI: 10.1111/nan.12495

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  51 in total

1.  Minicolumn thinning in temporal lobe association cortex but not primary auditory cortex in normal human ageing.

Authors:  Steven A Chance; Manuel F Casanova; Andy E Switala; Timothy J Crow; Margaret M Esiri
Journal:  Acta Neuropathol       Date:  2006-02-22       Impact factor: 17.088

2.  Neuropathological findings in chorea-acanthocytosis: new insights into mechanisms underlying parkinsonism and seizures.

Authors:  Barbara S Connolly; Lili-Naz Hazrati; Anthony E Lang
Journal:  Acta Neuropathol       Date:  2014-01-07       Impact factor: 17.088

3.  Minicolumnar abnormalities in autism.

Authors:  Manuel F Casanova; Imke A J van Kooten; Andrew E Switala; Herman van Engeland; Helmut Heinsen; Harry W M Steinbusch; Patrick R Hof; Juan Trippe; Janet Stone; Christoph Schmitz
Journal:  Acta Neuropathol       Date:  2006-07-04       Impact factor: 17.088

4.  Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis.

Authors:  C Dobson-Stone; A Danek; L Rampoldi; R J Hardie; R M Chalmers; N W Wood; S Bohlega; M T Dotti; A Federico; M Shizuka; M Tanaka; M Watanabe; Y Ikeda; M Brin; L G Goldfarb; B I Karp; S Mohiddin; L Fananapazir; A Storch; A E Fryer; P Maddison; I Sibon; P C Trevisol-Bittencourt; C Singer; I R Caballero; J O Aasly; K Schmierer; R Dengler; L-P Hiersemenzel; M Zeviani; V Meiner; A Lossos; S Johnson; F C Mercado; G Sorrentino; N Dupré; G A Rouleau; J Volkmann; J Arpa; A Lees; G Geraud; S Chouinard; A Németh; A P Monaco
Journal:  Eur J Hum Genet       Date:  2002-11       Impact factor: 4.246

5.  Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease.

Authors:  Alissa L Nana; Eric H Kim; Doris C V Thu; Dorothy E Oorschot; Lynette J Tippett; Virginia M Hogg; Beth J Synek; Richard Roxburgh; Henry J Waldvogel; Richard L M Faull
Journal:  J Huntingtons Dis       Date:  2014

Review 6.  The neuropathological features of neuroacanthocytosis.

Authors:  J O Rinne; S E Daniel; F Scaravilli; M Pires; A E Harding; C D Marsden
Journal:  Mov Disord       Date:  1994-05       Impact factor: 10.338

7.  Volume, neuron density and total neuron number in five subcortical regions in schizophrenia.

Authors:  Pawel Kreczmanski; Helmut Heinsen; Valentina Mantua; Fritz Woltersdorf; Thorsten Masson; Norbert Ulfig; Rainald Schmidt-Kastner; Hubert Korr; Harry W M Steinbusch; Patrick R Hof; Christoph Schmitz
Journal:  Brain       Date:  2007-02-15       Impact factor: 13.501

8.  Cortical interneuron loss and symptom heterogeneity in Huntington disease.

Authors:  Eric H Kim; Doris C V Thu; Lynette J Tippett; Dorothy E Oorschot; Virginia M Hogg; Richard Roxburgh; Beth J Synek; Henry J Waldvogel; Richard L M Faull
Journal:  Ann Neurol       Date:  2014-05-13       Impact factor: 10.422

Review 9.  Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease.

Authors:  John H Morrison; Patrick R Hof
Journal:  Prog Brain Res       Date:  2002       Impact factor: 2.453

10.  Cortical and striatal neurone number in Huntington's disease.

Authors:  H Heinsen; M Strik; M Bauer; K Luther; G Ulmar; D Gangnus; G Jungkunz; W Eisenmenger; M Götz
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more
  4 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

2.  Association of sleep disturbance and freezing of gait in Parkinson disease: prevention/delay implications.

Authors:  Xiaohui Tang; Lijia Yu; Jingyun Yang; Wenjing Guo; Ying Liu; Yaling Xu; Xijin Wang
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

3.  Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis.

Authors:  Kevin Peikert; Enrica Federti; Andreas Hermann; Lucia De Franceschi; Alessandro Matte; Gabriela Constantin; Enrica Caterina Pietronigro; Paolo Francesco Fabene; Paola Defilippi; Emilia Turco; Federico Del Gallo; Pietro Pucci; Angela Amoresano; Anna Illiano; Flora Cozzolino; Maria Monti; Francesca Garello; Enzo Terreno; Seth Leo Alper; Hannes Glaß; Lisann Pelzl; Katja Akgün; Tjalf Ziemssen; Rainer Ordemann; Florian Lang; Anna Maria Brunati; Elena Tibaldi; Immacolata Andolfo; Achille Iolascon; Giuseppe Bertini; Mario Buffelli; Carlo Zancanaro; Erika Lorenzetto; Angela Siciliano; Massimiliano Bonifacio; Adrian Danek; Ruth Helen Walker
Journal:  Acta Neuropathol Commun       Date:  2021-05-03       Impact factor: 7.801

4.  Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.

Authors:  Kevin Peikert; Hannes Glaß; Enrica Federti; Alessandro Matte; Lisann Pelzl; Katja Akgün; Tjalf Ziemssen; Rainer Ordemann; Florian Lang; The Network For Translational Research For Neuroacanthocytosis Patients; Lucia De Franceschi; Andreas Hermann
Journal:  J Pers Med       Date:  2021-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.